M28 Capital Management LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
M28 Capital Management LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,810,776
-48.8%
216,600
+52.0%
2.08%
-55.6%
Q2 2023$3,539,700
-30.7%
142,500
-58.0%
4.68%
-19.0%
Q1 2023$5,106,080
+313.4%
339,500
+225.2%
5.77%
+390.5%
Q4 2022$1,235,052
-38.4%
104,400
-69.2%
1.18%
-43.8%
Q3 2022$2,006,000
-35.0%
338,800
-53.3%
2.09%
-39.5%
Q2 2022$3,086,000
-69.0%
726,200
-30.7%
3.46%
-62.3%
Q1 2022$9,966,000
-0.5%
1,047,900
+98.8%
9.16%
+17.2%
Q4 2021$10,013,000527,0007.82%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders